Lactosylceramide recruits PKCα/ε and phospholipase A ₂ to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells

Despite the importance of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in the adhesion and diapedesis of monocytes/lymphocytes, little is known about the mechanisms by which it is regulated. We explored the role of a glycosphingolipid, lactosylceramide (LacCer), in modulating PECAM-1 expression and cell adhesion in human monocytes. We observed that LacCer specifically exerted a time-dependent increase in PECAM-1 expression in U-937 cells. Maximal increase in PECAM-1 protein occurred after incubation with LacCer for 60 min. LacCer activated PKCα and -ε by translocating them from cytosol to membrane. This was accompanied by the activation of phospholipase A₂ (PLA₂) and the increase of cell adhesion, which were abrogated by chelerythrine chloride, 2-[1-(3-dimethylaminopropyl)-lH-indol-3-yl]-3-(1H-indol-3-yl)-maleimide and 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a) pyrrolo(3,4-c)-carbazole (GÖ 6976) (PKC inhibitors). Similarly, bromoenol lactone (a Ca²⁺-independent PLA₂ inhibitor) and methyl arachidonyl fluorophosphonate (an inhibitor of cytosolic PLA₂ and Ca²⁺-independent PLA2) inhibited LacCer-induced PLA₂ activity. Bromophenacyl bromide (a PLA₂ inhibitor) abrogated LacCer-induced PECAM-1 expression, and this was bypassed by arachidonic acid. Furthermore, the arachidonate-induced up-regulation of PECAM-1 was abrogated by indomethacin [a cyclooxygenase (COX)-1 and -2 inhibitor] or N-[2-(cyclohexyloxy)-4-nitrophenyl]-methanesulfonamide (a COX-2 inhibitor) but not nordihydroguaiaretic acid (a lipoxygenase inhibitor). In sum, PKCα/ε are the primary targets for the activation of LacCer. Downstream activation of intracellular Ca²⁺-independent PLA ₂ and/or cytosolic PLA₂ results in the production of arachidonic acid, which in turn serves as a precursor for prostaglandins that subsequently stimulate PECAM-1 expression and cell adhesion. These findings may be relevant in explaining the role of LacCer in the regulation of PECAM-1 and related pathophysiology.